Paediatric Inflammatory Bowel Disease

Paediatric Inflammatory Bowel Disease: : A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents  Background and Aims: Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two ap[1]proved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [IBD]. There are…

Details